Amber Jackson was Appointed as Associate Director, Talent Acquisition Programs and Operations at Moderna Therapeutics

Date of management change: October 17, 2019 

What Happened?

Cambridge, MA-based Moderna Therapeutics Appointed Amber Jackson as Associate Director, Talent Acquisition Programs and Operations


About the Company

Moderna is a clinical stage pioneer of messenger RNA Therapeutics™, an entirely new in vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. This breakthrough platform addresses currently undruggable targets and offers a superior alternative to existing drug modalities for a wide range of diseases and conditions. Moderna is developing and plans to commercialize its innovative mRNA drugs through its own ventures and its strategic relationships with established pharmaceutical and biotech companies. Its current ventures are: Onkaido, focused on oncology, Valera, focused on infectious diseases, Elpidera, focused on rare diseases, and Caperna, focused on personalized cancer vaccines. Cambridge-based Moderna is privately held and currently has strategic agreements with AstraZeneca, Alexion Pharmaceuticals and Merck.


About the Person

Amber Jackson is Associate Director, Talent Acquisition Programs and Operations at Moderna Therapeutics. Previously, Amber held various senior HR leadership roles in the industry.


Info Source



Other IT executives who recently changed jobs as well: Gmeiner Mary, Kingsmill Stephani, Decker Bill, Ranieri Richard, Bunce Lisa, Becich Julia, Reid Amanda, Norris Robin, Duke Megan, Brown Angelique, Loring Kurt

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.